This SuperSeries is composed of the SubSeries listed below.
STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain.
Cell line
View SamplesActivation of Signal Transducer and Activator of Transcription 3 (STAT3) is common in prostate cancers. STAT3 may induce cell proliferation and resistance to apoptosis, as well as promote tumor angiogenesis, invasion, and migration by activating gene expression. Many STAT3-dependent transcriptional responses are mediated through protein-protein interactions that involve the amino-terminal domain (N-domain).
STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain.
Cell line
View SamplesActivation of Signal Transducer and Activator of Transcription 3 (STAT3) is common in prostate cancers. STAT3 may induce cell proliferation and resistance to apoptosis, as well as promote tumor angiogenesis, invasion, and migration by activating gene expression. Many STAT3-dependent transcriptional responses are mediated through protein-protein interactions that involve the amino-terminal domain (N-domain).
STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain.
Cell line
View SamplesAfrican-American (AA) men experience increased risk of developing prostate cancers as well as increased mortality following treatment as compared to European-American (EA) men. The aim of our study was to identify biological factors with potential to predispose AA men to prostate tumor progression and metastasis.
Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men.
No sample metadata fields
View SamplesThis SuperSeries is composed of the SubSeries listed below.
Cross-study homogeneity of psoriasis gene expression in skin across a large expression range.
Sex, Specimen part, Time
View SamplescDNA and cRNA hybridization technologies have different, probe-specific sensitivities. We used samples from an etanercept trial (GSE11903) to explore in a real-life setting the uniqueness of each platform.
Cross-study homogeneity of psoriasis gene expression in skin across a large expression range.
Specimen part, Time
View SamplesTo explore the psoriasis phenotype and pathways involved in psoriasis, we characterized gene expression in lesional and non-lesional skin from psoriasis patients.
Cross-study homogeneity of psoriasis gene expression in skin across a large expression range.
Specimen part
View SamplesTo explore the psoriasis phenotype, we characterize gene expression in lesional and non-lesional skin from psoriasis patients.
Cross-study homogeneity of psoriasis gene expression in skin across a large expression range.
Sex, Specimen part
View SamplesRobust identification of placental PPARg target genes via mutliple PPARg-dependence criteria.
Placental PPARĪ³ regulates spatiotemporally diverse genes and a unique metabolic network.
Specimen part
View SamplesTo explore the psoriasis phenotype and pathways involved in psoriasis, we characterized gene expression in lesional and non-lesional skin from psoriasis patients. Furthermore, we explored the effects of various doses of brodalumab on lesional skin over time.
Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody.
Specimen part, Disease, Disease stage, Treatment, Subject, Time
View Samples